-
-
-
-
-
-
-
Alexion Pharma (ALXN) Announces Upcoming Data Presentations at the 26th European Hematology Association Virtual Congress
-
-
-
-
-
-
-
Alexion Pharmaceuticals (ALXN) PT Lowered to $190 at Credit Suisse, Following Earnings
-
-
-
-
-
-
-
AstraZeneca (AZN) to Acquire Alexion Pharma (ALXN) for $39B, or $175/Share
-
-
-
-
-
-
-
Alexion Reports Third Quarter 2020 Results
-
-
-
-
-
-
-
Alexion Pharma (ALXN) Announces ULTOMIRIS Receives Approval in Japan for Atypical Hemolytic Uremic Syndrome in Adults and Children
-
-
-
-
-
-
-
Alexion Pharmaceuticals (ALXN) PT Raised to $155 at SunTrust, Following Earnings
-
-
-
-
-
-
-
Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

